表紙
市場調查報告書

永久的人造皮膚的全球市場:2020年∼2024年

Global Permanent Artificial Skin Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 781942
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
永久的人造皮膚的全球市場:2020年∼2024年 Global Permanent Artificial Skin Market 2020-2024
出版日期: 2020年03月19日內容資訊: 英文 120 Pages
簡介

全球永久的人造皮膚市場在2020年∼2025年的預測期間內,預計將以19%的年複合成長率增長,達到44億1,000萬美元的規模。研究開發資金的增加是市場主要的成長要素。此外發展中國家可獲得具有成本效益的治療方法,預計將推動全球市場增長。

本報告提供全球永久的人造皮膚市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年到2024年的預測

波特的五力分析

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模與預測2019-2024
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區
  • 主要國家
  • 各地區的市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 交易量的成長要素-供給主導型成長
  • 交易量的成長要素-外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格上升要素-通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AVITA Medical Ltd.
  • Aroa Biosurgery Ltd.
  • Eucare Pharmaceuticals Pvt. Ltd.
  • Integra LifeSciences Corp.
  • Mallinckrodt Plc
  • MedSkin Solutions Dr. Suwelack AG
  • MiMedx Group Inc.
  • Misonix Inc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR41631

Technavio has been monitoring the global permanent artificial skin market and it is poised to grow by USD 4.41 bn during 2020-2024, progressing at a CAGR of 19% during the forecast period. Our reports on global permanent artificial skin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in R&D funding. In addition, availability of cost-effective treatment in developing countries is anticipated to boost the growth of the global permanent artificial skin market as well.

Market Segmentation

Technavio's ‘ global permanent artificial skin market ’ is segmented as below:

End-User:

  • Hospitals
  • Other Healthcare Centers

Geographic segmentation

  • North America
  • Europe
  • APAC
  • ROW

Key Trends for global permanent artificial skin market growth

This study identifies availability of cost-effective treatment in developing countries as the prime reasons driving the global permanent artificial skin market growth during the next few years.

Prominent vendors in global permanent artificial skin market

We provide a detailed analysis of around 25 vendors operating in the global permanent artificial skin market 2020-2024, including some of the vendors such as AVITA Medical Ltd., Aroa Biosurgery Ltd., Eucare Pharmaceuticals Pvt. Ltd., Integra LifeSciences Corp., Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, MiMedx Group Inc., Misonix Inc., Organogenesis Holdings Inc. and Smith & Nephew Plc .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AVITA Medical Ltd.
  • Aroa Biosurgery Ltd.
  • Eucare Pharmaceuticals Pvt. Ltd.
  • Integra LifeSciences Corp.
  • Mallinckrodt Plc
  • MedSkin Solutions Dr. Suwelack AG
  • MiMedx Group Inc.
  • Misonix Inc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Market in focus
  • 9.Parent market
  • 12.Market characteristics
  • 14.Offerings of vendors included in the market definition
  • 16.Market segments
  • 21.Global - Market size and forecast 2019 - 2024 ($ million)
  • 22.Global market: Year-over-year growth 2019 - 2024 (%)
  • 23.Five forces analysis 2019 & 2024
  • 25.Bargaining power of buyers
  • 26.Bargaining power of suppliers
  • 27.Threat of new entrants
  • 28.Threat of substitutes
  • 29.Threat of rivalry
  • 31.Market condition - Five forces 2019
  • 32.Customer landscape
  • 33.Market share by geography 2019-2024 (%)
  • 34.Geographic comparison
  • 36.North America - Market size and forecast 2019-2024 ($ million)
  • 37.North America - Year-over-year growth 2019-2024 (%)
  • 39.Europe - Market size and forecast 2019-2024 ($ million)
  • 40.Europe - Year-over-year growth 2019-2024 (%)
  • 42.APAC - Market size and forecast 2019-2024 ($ million)
  • 43.APAC - Year-over-year growth 2019-2024 (%)
  • 45.ROW - Market size and forecast 2019-2024 ($ million)
  • 46.ROW - Year-over-year growth 2019-2024 (%)
  • 47.Key leading countries
  • 48.Market opportunity by geography ($ million)
  • 49.Impact of drivers and challenges
  • 50.Vendor landscape
  • 52.Landscape disruption
  • 54.Industry risk
  • 56.Vendors covered
  • 58.Market positioning of vendors
  • 60.AVITA Medical Ltd. - Overview
  • 61.AVITA Medical Ltd. - Business segments
  • 62.AVITA Medical Ltd. - Key offerings
  • 63.AVITA Medical Ltd. - Key customers
  • 64.AVITA Medical Ltd. - Segment focus
  • 66.Aroa Biosurgery Ltd. - Overview
  • 67.Aroa Biosurgery Ltd. - Product and service
  • 68.Aroa Biosurgery Ltd. - Key offerings
  • 69.Aroa Biosurgery Ltd. - Key customers
  • 70.Aroa Biosurgery Ltd. - Segment focus
  • 72.Eucare Pharmaceuticals Pvt. Ltd. - Overview
  • 73.Eucare Pharmaceuticals Pvt. Ltd. - Product and service
  • 74.Eucare Pharmaceuticals Pvt. Ltd. - Key offerings
  • 75.Eucare Pharmaceuticals Pvt. Ltd. - Key customers
  • 76.Eucare Pharmaceuticals Pvt. Ltd. - Segment focus
  • 78.Integra LifeSciences Corp. - Overview
  • 79.Integra LifeSciences Corp. - Business segments
  • 80.Integra LifeSciences Corp. - Key offerings
  • 81.Integra LifeSciences Corp. - Key customers
  • 82.Integra LifeSciences Corp. - Segment focus
  • 84.Mallinckrodt Plc - Overview
  • 85.Mallinckrodt Plc - Business segments
  • 86.Mallinckrodt Plc - Key offerings
  • 87.Mallinckrodt Plc - Key customers
  • 88.Mallinckrodt Plc - Segment focus
  • 90.MedSkin Solutions Dr. Suwelack AG - Overview
  • 91.MedSkin Solutions Dr. Suwelack AG - Product and service
  • 92.MedSkin Solutions Dr. Suwelack AG - Key offerings
  • 93.MedSkin Solutions Dr. Suwelack AG - Key customers
  • 94.MedSkin Solutions Dr. Suwelack AG - Segment focus
  • 96.MiMedx Group Inc. - Overview
  • 97.MiMedx Group Inc. - Business segments
  • 98.MiMedx Group Inc. - Key offerings
  • 99.MiMedx Group Inc. - Key customers
  • 100.MiMedx Group Inc. - Segment focus
  • 102.Misonix Inc. - Overview
  • 103.Misonix Inc. - Business segments
  • 104.Misonix Inc. - Key offerings
  • 105.Misonix Inc. - Key customers
  • 106.Misonix Inc. - Segment focus
  • 108.Organogenesis Holdings Inc. - Overview
  • 109.Organogenesis Holdings Inc. - Business segments
  • 110.Organogenesis Holdings Inc. - Key offerings
  • 111.Organogenesis Holdings Inc. - Key customers
  • 112.Organogenesis Holdings Inc. - Segment focus
  • 114.Smith & Nephew Plc - Overview
  • 115.Smith & Nephew Plc - Business segments
  • 116.Smith & Nephew Plc - Key offerings
  • 117.Smith & Nephew Plc - Key customers
  • 118.Smith & Nephew Plc - Segment focus
  • 120.Currency conversion rates for US$
  • 121.Research Methodology
  • 122.Validation techniques employed for market sizing
  • 123.Information sources
  • 124.List of abbreviations